Cargando…
Identification of CD44 as a Reliable Biomarker for Glioblastoma Invasion: Based on Magnetic Resonance Imaging and Spectroscopic Analysis of 5-Aminolevulinic Acid Fluorescence
Recurrent glioblastoma multiforme (GBM) is largely attributed to peritumoral infiltration of tumor cells. As higher CD44 expression in the tumor periphery correlates with higher risk of GBM invasion, the present study analyzed the relationship between CD44 expression and magnetic resonance imaging (...
Autores principales: | Inoue, Akihiro, Ohnishi, Takanori, Nishikawa, Masahiro, Watanabe, Hideaki, Kusakabe, Kosuke, Taniwaki, Mashio, Yano, Hajime, Ohtsuka, Yoshihiro, Matsumoto, Shirabe, Suehiro, Satoshi, Yamashita, Daisuke, Shigekawa, Seiji, Takahashi, Hisaaki, Kitazawa, Riko, Tanaka, Junya, Kunieda, Takeharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525185/ https://www.ncbi.nlm.nih.gov/pubmed/37760811 http://dx.doi.org/10.3390/biomedicines11092369 |
Ejemplares similares
-
Perioperative perampanel administration for early seizure prophylaxis in brain tumor patients
por: Kusakabe, Kosuke, et al.
Publicado: (2023) -
Usefulness of neuroimaging and immunohistochemical study for accurate diagnosis of parasagittal hemangioblastoma arising in the supratentorial region: a case report and review of the literature
por: Kanehisa, Kota, et al.
Publicado: (2022) -
Utility of surgical tumor resection for normal-pressure hydrocephalus associated with spinal schwannoma in the cauda equina: A case report and review of the literature
por: Murayama, Kentaro, et al.
Publicado: (2022) -
CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021) -
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021)